Drug prices trend down in second quarter ASP list

Why This Topic Matters

Quarterly ASP updates can affect reimbursement for Medicare Part B drug claims and help billing teams anticipate payment changes. Readers who work with drug administration, charge capture, or payment analysis can use this article to understand the scope of the quarter’s pricing movement and review the most significant shifts.

Article Sections

1. Quarterly ASP pricing overview

   Summarizes the overall direction of second-quarter Medicare Part B ASP pricing and the volume of drugs affected by increases, decreases, or no change.

2. Top billed drugs with a payment increase

   Presents a ranked view of selected Part B drugs with larger payment increases for the quarter.

3. Top billed drugs with a payment decrease

   Presents a ranked view of selected Part B drugs with larger payment decreases for the quarter.

4. Source and timing notes

   Identifies the CMS ASP list source used in the analysis and notes the effective period for the second-quarter pricing changes.